Cargando…

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma

Little is known about the immune environment of ovarian clear cell carcinoma (OCCC) and its impact on various ethnic backgrounds. The aim of this OCCC immune‐related gene expression signatures (irGES) study was to address the interaction between tumour and immune environment of ethnically‐diverse As...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heong, Valerie, Tan, Tuan Z, Miwa, Maiko, Ye, Jieru, Lim, Diana, Herrington, C Simon, Iida, Yasushi, Yano, Mitsutake, Yasuda, Masanori, Ngoi, Natalie YL, Wong, SB Justin, Okamoto, Aikou, Gourley, Charlie, Hasegawa, Kosei, Tan, David SP, Huang, Ruby YJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2021
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539643/ https://www.ncbi.nlm.nih.gov/pubmed/34322886 http://dx.doi.org/10.1002/path.5769

Ejemplares similares

Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
por: Yano, Mitsutake, et al.
Publicado: (2019)

Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma
por: Zaitsu, Sumika, et al.
Publicado: (2023)

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
por: Tan, Tuan Zea, et al.
Publicado: (2019)

A unique uterine cervical “teratocarcinosarcoma”: a case report
por: Ito, Kozue, et al.
Publicado: (2019)

The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers
por: Ngoi, Natalie YL, et al.
Publicado: (2019)

Exploiting replicative stress in gynecological cancers as a therapeutic strategy
por: Ngoi, Natalie YL, et al.
Publicado: (2020)

Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
por: Suzuki, Hiroyuki, et al.
Publicado: (2019)

Update on immune checkpoint inhibitors in gynecological cancers
por: Heong, Valerie, et al.
Publicado: (2017)

The prognostic significance of tumor lymphangiogenesis and lymphatic vessel density in endometrioid carcinoma of the uterine corpus
por: Sakaki, Mika, et al.
Publicado: (2017)

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
por: Ngoi, Natalie YL, et al.
Publicado: (2020)

An Unusual Ovarian Mucinous Borderline Tumor with a Large Solid Component
por: Kozawa, Eito, et al.
Publicado: (2019)

Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report
por: Yano, Mitsutake, et al.
Publicado: (2019)

The FZD7‐TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma
por: Tan, Ming, et al.
Publicado: (2019)

Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma
por: Yabuno, Akira, et al.
Publicado: (2020)

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
por: Hollis, Robert L., et al.
Publicado: (2020)

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
por: Langdon, Simon P., et al.
Publicado: (2020)

Association of histone deacetylase expression with histology and prognosis of ovarian cancer
por: Yano, Mitsutake, et al.
Publicado: (2018)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

Significance of PD-L1 Expression in Tongue Cancer Development
por: Yoshida, Saori, et al.
Publicado: (2018)

Tumor-to-tumor metastasis from appendiceal adenocarcinoma to an ovarian mature teratoma, mimicking malignant transformation of a teratoma: a case report
por: Yano, Mitsutake, et al.
Publicado: (2019)

Uterine intravenous leiomyomatosis with an isolated large metastasis to the right atrium: a case report
por: Yano, Mitsutake, et al.
Publicado: (2020)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma
por: Hollis, Robert L., et al.
Publicado: (2019)

Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
por: Ngoi, N.Y.L., et al.
Publicado: (2018)

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
por: Lee, Yong Jae, et al.
Publicado: (2021)

Preponderance of endometrial carcinoma in elderly patients
por: Ogane, Naoki, et al.
Publicado: (2018)

Synchronous mucinous metaplasia and neoplasia of the female genital tract with external urethral meatus neoplasm: A case report
por: Ikeda, Yuji, et al.
Publicado: (2015)

MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma
por: Yanaihara, Nozomu, et al.
Publicado: (2016)

Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma
por: Seki, Toshiyuki, et al.
Publicado: (2021)

SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers 2020, 12, 1140
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report
por: Yano, Mitsutake, et al.
Publicado: (2018)

Podoplanin is an efficient predictor of neck lymph node metastasis in tongue squamous cell carcinoma with low tumor budding grade
por: Hamada, Mei, et al.
Publicado: (2020)

Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
por: Hollis, Robert L., et al.
Publicado: (2022)

Does Clear Corneal Cataract Surgery Influence Conjunctivochalasis?
por: Mimura, Tatsuya, et al.
Publicado: (2020)

CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype
por: Tan, Tuan Zea, et al.
Publicado: (2015)

Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive
por: Gourley, Charlie
Publicado: (2019)

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014)

CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells
por: Kawabata, Ayako, et al.
Publicado: (2022)

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
por: Kim, Yoo-Na, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nu4jumqegvm4ekgp49vakcd69u